EUVIMEDEUVIMED entdecken
Crossref

Discovery of 2(1 H )-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers

Chunzheng Li, Xiaojing Lan, Xinge Li, Yixian Fu, Gang Gui, Xiaodong Li, Yanyan Shen, Zhenjie Gan, Min Huang, Xiaoming Zha iD

Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 1222-1244

DOI: 10.1021/acs.jmedchem.4c01635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.01.2025. Verfasst von Chunzheng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China. Hauptthemen laut MEDLINE: Quinoxalines, Methionine Adenosyltransferase, Antineoplastic Agents, Purine-Nucleoside Phosphorylase. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Qinglan Project of Jiangsu Province of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methionine adenosyltransferase 2A (MAT2A) has emerged as a synthetic lethal drug target in cancers bearing homozygous methylthioadenosine phosphorylase (MTAP) gene deletion. Despite the remarkable progress in the discovery and development of MAT2A inhibitors, current understanding about the selectivity of these compounds toward MTAP-deficient cancers is relatively limited. To improve the selectivity of MAT2A inhibitors for MTAP-deficient cancers remains a significant challenge. We herein reported the discovery of a series of novel MAT2A inhibitors with a 2(1H)-quinoxalinone scaffold through structure-based drug design and systematic SAR exploration. Among them, compound 28 exhibited good inhibitory activity against the enzymatic activity of MAT2A, and the significantly improved selectivity in killing MTAP-deficient cancer cells. Compound 28 also showed favorable pharmacokinetic properties and the improved in vivo anticancer activity in MTAP-deficient tumor models. These findings suggest new directions for the discovery and development of highly selective MAT2A inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinoxalinesMethionine AdenosyltransferaseAntineoplastic AgentsPurine-Nucleoside PhosphorylaseHumansAnimalsStructure-Activity RelationshipCell Line, TumorEnzyme InhibitorsMiceDrug DiscoveryNeoplasmsXenograft Model Antitumor AssaysDrug Design

Substanzen

5'-methylthioadenosine phosphorylaseQuinoxalinesMethionine AdenosyltransferaseMAT2A protein, humanAntineoplastic AgentsPurine-Nucleoside PhosphorylaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 201203, China.

ORCID-Profile: Xiaoming Zha

Förderung

  • Qinglan Project of Jiangsu Province of China
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Li, C., Lan, X., Li, X., Fu, Y., Gui, G., Li, X., Shen, Y., Gan, Z., Huang, M., & Zha, X. (2025). Discovery of 2(1 H )-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers. Journal of Medicinal Chemistry, 68(2), 1222-1244. https://doi.org/10.1021/acs.jmedchem.4c01635

Vancouver

Li C, Lan X, Li X, Fu Y, Gui G, Li X, et al. Discovery of 2(1 H )-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers. Journal of Medicinal Chemistry. 2025;68(2):1222-1244. doi:10.1021/acs.jmedchem.4c01635

BibTeX
@article{Li2025,
  author = {Li, Chunzheng and Lan, Xiaojing and Li, Xinge and Fu, Yixian and Gui, Gang and Li, Xiaodong and Shen, Yanyan and Gan, Zhenjie and Huang, Min and Zha, Xiaoming},
  title = {Discovery of 2(1 H )-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {2},
  pages = {1222--1244},
  doi = {10.1021/acs.jmedchem.4c01635}
}
Kostenlos starten →